Immunotherapy Biomarkers

Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination
Laura E. Johnson, Brian M. Olson, Douglas G. McNeel

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 56; DOI: 10.1186/s40425-017-0260-3
Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy
Gail D. Sckisel, Annie Mirsoian, Christine M. Minnar, Marka Crittenden, Brendan Curti, Jane Q. Chen, Bruce R. Blazar, Alexander D. Borowsky, Arta M. Monjazeb, William J. Murphy

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 33; DOI: 10.1186/s40425-017-0235-4
Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma
James W. Smithy, Lauren M. Moore, Vasiliki Pelekanou, Jamaal Rehman, Patricia Gaule, Pok Fai Wong, Veronique M. Neumeister, Mario Sznol, Harriet M. Kluger, David L. Rimm

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 25; DOI: 10.1186/s40425-017-0229-2
Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody
Renee N. Donahue, Lauren M. Lepone, Italia Grenga, Caroline Jochems, Massimo Fantini, Ravi A. Madan, Christopher R. Heery, James L. Gulley, Jeffrey Schlom

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 20; DOI: 10.1186/s40425-017-0220-y
Gene expression markers of Tumor Infiltrating Leukocytes
Patrick Danaher, Sarah Warren, Lucas Dennis, Leonard D’Amico, Andrew White, Mary L. Disis, Melissa A. Geller, Kunle Odunsi, Joseph Beechem, Steven P. Fling

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 18; DOI: 10.1186/s40425-017-0215-8
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide
Ioannis F. Voutsas, Eleftheria A. Anastasopoulou, Panagiotis Tzonis, Michael Papamichail, Sonia A. Perez, Constantin N. Baxevanis

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 75; DOI: 10.1186/s40425-016-0183-4
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation
Giuseppe V. Masucci, Alessandra Cesano, Rachael Hawtin, Sylvia Janetzki, Jenny Zhang, Ilan Kirsch, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Z. Streicher, Lisa H. Butterfield, Magdalena Thurin

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 76; DOI: 10.1186/s40425-016-0178-1
Biomarkers immune monitoring technology primer: Immunoscore® Colon
Fabienne Hermitte

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 57; DOI: 10.1186/s40425-016-0161-x
Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial
Jason J. Luke, Yuanyuan Zha, Karen Matijevich, Thomas F. Gajewski

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 35; DOI: 10.1186/s40425-016-0140-2
Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients
Vishwajith Sridharan, Danielle N. Margalit, Stephanie A. Lynch, Mariano Severgnini, F. Stephen Hodi, Robert I. Haddad, Roy B. Tishler, Jonathan D. Schoenfeld

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 32; DOI: 10.1186/s40425-016-0138-9

Main menu

Immunotherapy Biomarkers

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy Biomarkers

Pages